Detection of genetic variations of regulator of G-protein signaling 2 in hypertensives by sequencing

Zhang JU-HONG; Li NAN-FANG; Yan ZHI-TAO; Yao XIAO-GUANG; Wang HONG-MEI; Zhang DE-LIAN; Wang XIN-LING.
Acta Academiae Medicinae Sinicae ; (6): 200-204, 2011.
Artículo en Inglés | WPRIM | ID: wpr-341431

Documentos relacionados

  1. Detection of genetic variations of regulator of G-protein signaling 2 in hypertensives by sequencing.
  2. RGS5 augments astrocyte activation and facilitates neuroinflammation via TNF signaling.
  3. An Interhelical Salt Bridge Controls Flexibility and Inhibitor Potency for Regulators of G-protein Signaling Proteins 4, 8, and 19.
  4. Functional Assessment of Cancer-Linked Mutations in Sensitive Regions of Regulators of G Protein Signaling Predicted by Three-Dimensional Missense Tolerance Ratio Analysis.
  5. "Mind the GAP": RGS1 hinders antitumor lymphocytes.
  6. <i>RGS3</i> and <i>IL1RAPL1</i> missense variants implicate defective neurotransmission in early-onset inherited schizophrenias.
  7. (Hyper)tension release by N-terminal acetylation.
  8. Age-Dependent RGS5 Loss in Pericytes Induces Cardiac Dysfunction and Fibrosis.
  9. Clinical and molecular implications of RGS2 promoter genetic variation in severe asthma.
  10. RGS7 balances acetylation/de-acetylation of p65 to control chemotherapy-dependent cardiac inflammation.